Home » Topics » Regulatory

Regulatory
RSS

Allergan ciclosporin NDA up for review this month by advisory committee

July 12, 1999

FDA advisory committee to consider OTC status for Flexeril

July 9, 1999

Pediatric formulation of Viramune now available in the E.U.

July 9, 1999

Novo Nordisk seeks approval for liquid GH in the U.S.

July 5, 1999

TAP Holdings seeks approval of erectile dysfunction treatment

July 2, 1999

FDA approves new formulation of Abbott's Norvir

July 1, 1999

Alza's Doxil approved in U.S. for treatment of refractory ovarian cancer

July 1, 1999

Genentech submits NDA to FDA for Nutropin Depot

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Fosamax receives FDA approval for glucocorticoid-induced osteoporosis

June 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...